Phosphorylation of murine p53, but not human p53, by MAP kinase in vitro and in cultured cells highlights species-dependent variation in post-translational modification
Open Access
- 9 December 1999
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 18 (52), 7602-7607
- https://doi.org/10.1038/sj.onc.1203137
Abstract
The p53 tumour suppressor protein is tightly regulated by protein-protein association, protein turnover and a variety of post-translational modifications. Multisite phosphorylation plays a major role in activating and in finely tuning p53 function. The proline rich domain of murine p53 is a substrate for phosphorylation, in vitro and in cultured cells, by the p42ERK2 and p44ERK1 mitogen-activated protein (MAP) kinases. However, to date there have been no reports of attempts to determine whether p53 from any other species is a substrate for MAP kinase. In this paper we confirm that murine p53 is targeted by recombinant MAP kinase and by MAP kinases in extracts of both murine and human cells. In contrast, human p53 is not a substrate for recombinant MAP kinase nor are there any detectable levels of protein kinase activity in stimulated human cell extracts which phosphorylate the proline rich domain of human p53 in vitro. Finally, although stimulation of murine fibroblasts with o-tetradecanolylphorbol 13-acetate (TPA), an indirect activator of the MAP kinase pathway, leads to site-specific phosphorylation of murine p53, similar treatment of human fibroblasts and epithelial cells showed no significant changes in the phosphorylation pattern. These data are consistent with accumulating evidence that significant species-dependent differences exist in the post-translational modification of p53.Keywords
This publication has 30 references indexed in Scilit:
- Increasing complexity of Ras signalingOncogene, 1998
- JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinasesOncogene, 1997
- Genomic instability and apoptosis are frequent in p53 deficient young miceOncogene, 1997
- Mitogen-activated protein kinase pathwaysCurrent Opinion in Cell Biology, 1997
- Structural Aspects of the p53 Protein in Relation to Gene Evolution: A Second LookJournal of Molecular Biology, 1996
- Transformation of Mammalian Cells by Constitutively Active MAP Kinase KinaseScience, 1994
- Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cellsCell, 1994
- Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 allelesCell, 1992
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Cell, 1992
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992